Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.4.2 and the prior Revision: v3.4.1 notice has been removed; the change is metadata-related and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice at the top of the page indicating possible updates and current operating status, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and QC/versioning metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0); removed older QC wording (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed. The change does not alter core content or functionality.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page gains a Locations section listing study sites by state (CA, FL, MD, MI, MO, NY) and removes the per-state location headers; the revision is updated to v3.3.3.SummaryDifference0.7%

- Check85 days agoChange DetectedPage version updated from v3.3.1 to v3.3.2. No substantive changes to study details, eligibility, or results are visible.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.